相关实验视频

Updated: Jul 23, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

精确的患者分层在食道癌症: 免疫化学疗法的生物标志物

Shogo Kumagai¹, Shohei Koyama², Kohei Shitara³

¹Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo/Kashiwa, Japan; Division of Cellular Signaling, Research Institute, National Cancer Center, Tokyo, Japan.

|July 11, 2023

概括

免疫化疗是晚期食道癌的关键治疗方法. 来自JUPITER-06和LUD2015-005试验的新生物标志物研究可能有助于选择最适应这种治疗的患者.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
基因组学就是基因组学.

背景情况:

免疫化疗是高级食道癌的标准第一线治疗方法.
识别预测生物标志物对于优化患者的治疗结果至关重要.

研究的目的:

探索用于预测晚期食道癌治疗反应的生物标志物.
为了利用免疫基因组分析来对患者进行分层.

主要方法:

对来自JUPITER-06临床试验的数据进行探索性分析.
对LUD2015-005临床试验数据的探索性分析.
免疫基因组分析以确定预测生物标志物.

主要成果:

在这两项试验中都确定了与治疗反应相关的生物标志物.
这些生物标志物有可能预测患者对免疫化学疗法的反应.

结论:

通过免疫基因组分析发现生物标志物可以增强晚期食道癌患者分层.
这些发现支持开发个性化治疗策略.

更多相关视频

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...